US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03

+4.110.60%

Number of Gainers:71

Number of Losers:69

Number of Flat:13

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:272.16M

Turnover:8.90B

Market Cap:479.85B

Float Cap:365.12B

Loading ...

Cardiol Therapeutics files $150M preliminary base shelf prospectus

Five Star Bancorp Director Donna Lucas Resigns Immediately

iSpecimen Gets NASDAQ Extension to Meet $2.5 Million Stockholders’ Equity Rule by Nov. 25

Alpha Teknova participates in a conference call with Craig-Hallum

Alzamend Neuro Q1 FY27 Net Loss Narrows 12% to $3.03 Million

Robinhood Markets Shares Down 1.07% at $112.12 in Extended Trade After Reporting August Operating Data

THOMSON REUTERS

Lyell Immunopharma advances LYL273 CAR T program

TransCode Therapeutics Appoints John Tattory as Interim CFO

Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock

Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit

Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement

Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million

TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO

Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11

Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately

THOMSON REUTERS

Transcode Therapeutics Announces Leadership Transition

THOMSON REUTERS

Press Release: TransCode Therapeutics Announces Leadership Transition

Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial

Robinhood Platform Assets Rise to $384 Billion at End-August 2026

Intapp CEO John T. Hall Disposes of $118,769 in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK4539/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.02655,"timestamp":1789156799999,"preClose":688.91504,"halted":0,"volume":272157313,"delay":0,"changeRate":0.005968,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":4.111511,"latestTime":"09-11 16:00:00 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":8901943117.280722,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322141,"peRate":139.801509,"turnoverRate":0.021443,"increases":71,"decrements":69,"flats":10,"marketCap":479852364396.5,"floatMarketCap":365120021896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322141","latestPrice":693.02655,"volume":272157313,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.021443,"peRate":139.801509,"marketCap":479852364396.5,"floatMarketCap":365120021896,"timestamp":1789156799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":69,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666164155","title":"Cardiol Therapeutics files $150M preliminary base shelf prospectus","url":"https://stock-news.laohu8.com/highlight/detail?id=2666164155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666164155?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074332,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics (CRDL) announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-files-150m-preliminary-base-shelf-prospectus-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cardiol-therapeutics-files-150m-preliminary-base-shelf-prospectus-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","CRDL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516627","title":"Five Star Bancorp Director Donna Lucas Resigns Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516627","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516627?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:01","pubTimestamp":1789074085,"startTime":"0","endTime":"0","summary":"Five Star Bancorp director Donna Lucas resigns immediatelyFive Star Bancorp director Donna Lucas resigned from the board on Sept. 4, 2026, effective immediately.Her departure was not linked to any dis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL7Qc95V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FSBC","BK4539","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516572","title":"iSpecimen Gets NASDAQ Extension to Meet $2.5 Million Stockholders’ Equity Rule by Nov. 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516572","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516572?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:00","pubTimestamp":1789074054,"startTime":"0","endTime":"0","summary":"iSpecimen gets Nasdaq extension to meet $2.5 million stockholders’ equity rule by Nov. 25iSpecimen received a Nasdaq notice granting an extension to regain compliance with Listing Rule 5550(b) on mini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9JDG3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4539","ISPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516699","title":"Alpha Teknova participates in a conference call with Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516699","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516699?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:50","pubTimestamp":1789073417,"startTime":"0","endTime":"0","summary":"Craig-Hallum holds a conference call with management on September 16 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-teknova-participates-in-a-conference-call-with-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-teknova-participates-in-a-conference-call-with-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4539","TKNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666426515","title":"Alzamend Neuro Q1 FY27 Net Loss Narrows 12% to $3.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666426515","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666426515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:31","pubTimestamp":1789072315,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Q1 FY27 net loss narrows 12% to $3.03 millionAlzamend Neuro posted a net loss of $3.03 million, widening 12% from a year earlier.Operating loss widened to $3.03 million as total operati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL7zjjtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666154855","title":"Robinhood Markets Shares Down 1.07% at $112.12 in Extended Trade After Reporting August Operating Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666154855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666154855?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:29","pubTimestamp":1789072186,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4521A3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","HOOY","BK4127","BLCK","HOOC","IAI","HOOZ","HOOG","HOOI","LU1861559042.SGD","ROBN","CRPT","HODU","HOOD","FINX","BK4547","HOOX","HOII","HOOW","BPAY","LU1861558580.USD","HOYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516839","title":"Lyell Immunopharma advances LYL273 CAR T program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516839?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:29","pubTimestamp":1789072155,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma ( ($LYEL) ) has issued an update. On September 10, 2026, Lyell Immunopharma announced it had completed the technology transfer f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-advances-lyl273-car-t-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-advances-lyl273-car-t-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4505","LYEL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515120","title":"TransCode Therapeutics Appoints John Tattory as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515120","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515120?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:26","pubTimestamp":1789072010,"startTime":"0","endTime":"0","summary":"BRIEF-TransCode Therapeutics Appoints John Tattory As Interim CFOSept 10 (Reuters)-Transcode Therapeutics IncRNAZ.O:TRANSCODE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONTRANSCODE THERAPEUTICS - TOM F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515162","title":"Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515162?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:23","pubTimestamp":1789071825,"startTime":"0","endTime":"0","summary":"Duolingo director William B. Gordon sells USD 1.43 million in Class A common stockDuolingo director William B. Gordon sold 10,000 Class A common shares on Sep. 8, 2026 at $143.83-$151.64.Holdings fell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbQT3M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4204","BK4588","DUOL","BK4539","DUOG","BK4613","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515154","title":"Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515154","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515154?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071757,"startTime":"0","endTime":"0","summary":"Ryan Specialty names Dave Przesiek CEO of Ryan Specialty Benefits unitRyan Specialty named Dave Przesiek president and CEO of Ryan Specialty Benefits, effective immediately.Przesiek joined the benefit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1p2N6w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","RYAN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515151","title":"Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515151?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071742,"startTime":"0","endTime":"0","summary":"Candel Therapeutics director Martine Zimmermann files initial beneficial ownership statementMartine Zimmermann filed an initial Form 3 as a director of Candel Therapeutics on Sept. 8, 2026.Disclaimer:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL259g1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051561","title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051561","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051561?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:18","pubTimestamp":1789071522,"startTime":"0","endTime":"0","summary":"Coinbase director Marc L Andreessen disposes of 13,676 shares worth $2.48 millionCoinbase disclosed Director Marc L. Andreessen sold 13,676 Class A common shares on Sep. 8, 2026.The shares sold at a w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL87BmYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCK","DAPP","07711","LU1861220207.SGD","FDIG","COIX","LU2360107671.USD","BK4112","09311","CONY","CONX","CRPT","BK4516","LU1861559042.SGD","BKCH","BITQ","COYY","BK4600","FINX","BK4588","LU1861558580.USD","BK4596","COIN","CONL","BK4554","BK4539","FIAT","COII","COIW","ICOI","09711","CONI","LU1861217088.USD","07311","BK4551","BK4595","COIA","BK4535","COIO","BK4585","IBLC","COIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515837","title":"TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515837","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515837?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:11","pubTimestamp":1789071074,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics CFO Tom Fitzgerald retires; John Tattory named interim CFOTransCode Therapeutics CFO Tom Fitzgerald retired. He resigned as CFO and as a director, effective immediately.John Tat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6Z06gW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ","WINT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513093","title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513093","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513093?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071028,"startTime":"0","endTime":"0","summary":"Flywire General Counsel Peter Butterfield disposes of shares worth $218,639.11Flywire General Counsel and CCO Peter Butterfield sold 12,156 shares of voting common stock on Sept. 8, 2026.Sale priced a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbG2GVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4106","BK4539","LU0757428866.USD","LU1815336091.USD","FLYW","BK4227","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513083","title":"Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513083?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513055","title":"Transcode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513055","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666156815","title":"Press Release: TransCode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666156815","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666156815?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":"Tom Fitzgerald, Chief Financial Officer, Announces his RetirementJohn Tattory, to become Interim Chief Financial OfficerBOSTON, Sept. 10, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNA","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513741","title":"Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513741?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:09","pubTimestamp":1789070965,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma expects 2027 FDA End-of-Phase 1 meeting for LYL273 colorectal cancer trialLyell Immunopharma completed a manufacturing transfer for LYL273, its GCC-targeted CAR T-cell candidate for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5qVy37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","LU2095319765.USD","LU0314104364.USD","LU2210149790.SGD","BK4139","BK4588","BK4505","BK4539","NDAQ","SG9999014039.USD","IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","LYEL","BCDF","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051373","title":"Robinhood Platform Assets Rise to $384 Billion at End-August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051373","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051373?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070872,"startTime":"0","endTime":"0","summary":"Robinhood platform assets rise to $384 billion at end-August 2026Robinhood reported August 2026 total platform assets of USD 384 billion, up 8% from July, up 26% year over year.Funded customers ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3ykjNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FINX","HOOX","HOOD","HOOG","BK4127","LU1861558580.USD","HOYY","HOOC","BK4547","HOOI","BPAY","HOOW","HOOZ","HOOY","LU1861559042.SGD","HODU","HOII","BLCK","ROBN","CRPT","BK4539","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137515","title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137515","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070865,"startTime":"0","endTime":"0","summary":"Intapp CEO John T. Hall disposes of $118,769 in common sharesIntapp CEO John T. Hall sold 3,000 common shares on Sep. 8 at a weighted-average USD 39.59.He exercised employee stock options for 3,000 sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8zsNKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","INTA","LU1815336091.USD","LU0757428866.USD","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":6,"totalSize":889,"code":"91000000","status":"200"}]}}